- Home
- CLMT vs TVTX Comparison
CLMT vs TVTX Comparison
Compare CLMT & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMT
- TVTX
- Stock Information
- Founded
- CLMT 1916
- TVTX 2008
- Country
- CLMT United States
- TVTX United States
- Employees
- CLMT N/A
- TVTX N/A
- Industry
- CLMT Oil & Gas Production
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- CLMT Energy
- TVTX Health Care
- Exchange
- CLMT Nasdaq
- TVTX Nasdaq
- Market Cap
- CLMT 1.4B
- TVTX 1.5B
- IPO Year
- CLMT 2006
- TVTX N/A
- Fundamental
- Price
- CLMT $17.34
- TVTX $23.41
- Analyst Decision
- CLMT Strong Buy
- TVTX Strong Buy
- Analyst Count
- CLMT 6
- TVTX 16
- Target Price
- CLMT $20.38
- TVTX $35.07
- AVG Volume (30 Days)
- CLMT 805.3K
- TVTX 2.6M
- Earning Date
- CLMT 11-07-2025
- TVTX 10-30-2025
- Dividend Yield
- CLMT N/A
- TVTX N/A
- EPS Growth
- CLMT N/A
- TVTX N/A
- EPS
- CLMT N/A
- TVTX N/A
- Revenue
- CLMT $4,070,400,000.00
- TVTX $333,865,000.00
- Revenue This Year
- CLMT $1.02
- TVTX $83.26
- Revenue Next Year
- CLMT $2.01
- TVTX $43.19
- P/E Ratio
- CLMT N/A
- TVTX N/A
- Revenue Growth
- CLMT N/A
- TVTX 87.94
- 52 Week Low
- CLMT $7.68
- TVTX $11.89
- 52 Week High
- CLMT $25.29
- TVTX $28.69
- Technical
- Relative Strength Index (RSI)
- CLMT 60.65
- TVTX 63.45
- Support Level
- CLMT $17.10
- TVTX $20.84
- Resistance Level
- CLMT $17.97
- TVTX $28.69
- Average True Range (ATR)
- CLMT 0.72
- TVTX 1.45
- MACD
- CLMT 0.16
- TVTX 0.60
- Stochastic Oscillator
- CLMT 70.00
- TVTX 53.94
About CLMT Calumet Specialty Products Partners L.P. Common Units
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.